Does taking Tylenol during pregnancy increase the risk of autism in children?
Confidence as of July 8, 2026
3 claims3 open questions
Our take
Current evidence has not established that prenatal Tylenol causes autism. Some observational studies report associations that are still under study.
Why we say this
Observational literature, 2013
Multiple studies have reported associations with autism, ADHD, or related outcomes.
ACOG, 2025
"The current weight of evidence does not support a causal link between prenatal acetaminophen use and neurodevelopmental disorders."
S.D.N.Y., 2023
The MDL court excluded plaintiffs’ general-causation experts under Rule 702.
This is not a claim of absolute truth. Read the whole story for more context.
as of July 8, 2026
This story tracks the evidence regarding whether prenatal exposure to acetaminophen (the active ingredient in Tylenol) causes autism spectrum disorder. The question has received substantial public attention due to observational epidemiology studies, professional medical guidance, and litigation. We track what primary research, official guidance, and court proceedings establish separately.
Where things stand
Multiple observational studies have reported statistical associations between prenatal acetaminophen exposure and later neurodevelopmental outcomes, including autism spectrum disorder. However, these studies face important limitations, including confounding, exposure measurement uncertainty, and inability to establish causation. Large sibling-controlled analyses have not found increased risk after accounting for familial factors. Regulatory agencies and major medical organizations have not concluded that a causal relationship has been established. Litigation concerning these claims has proceeded independently of the scientific evidence and has included federal court rulings regarding the admissibility of expert testimony.
Soon you'll be able to follow a story and get notified when the evidence changes.
Confidence
as of July 8, 2026The strongest available evidence consists primarily of observational cohort and case-control studies, systematic reviews, and meta-analyses. These can identify statistical associations but are generally limited in their ability to determine causation because treatment is not randomly assigned and important confounding factors may remain. Sibling-controlled studies that better account for shared familial factors have not found increased autism or ADHD risk. Scientific reviews continue to evaluate whether observed associations reflect a causal effect, underlying maternal illness, genetic factors, indication for medication use, or other sources of bias.
This is our best read given the published evidence we have reviewed — not a claim of absolute truth.
Open questions
To what extent are observed associations explained by confounding — when a hidden third factor distorts an experiment's results?
Maternal illness, fever, genetics, and other factors may influence both acetaminophen use and child neurodevelopment.
Can future studies better measure dose, timing, and duration of prenatal exposure?
Many existing studies rely on self-reported medication use or incomplete exposure records.
Are there biological mechanisms that independently support causation?
Mechanistic evidence could strengthen or weaken causal interpretations of observational findings.
What would change our mind
- Multiple independent studies using methods that substantially reduce confounding and consistently demonstrate a causal relationship.
- New primary evidence that explains previously observed associations through measured confounding or bias.
- Updated systematic reviews or regulatory assessments concluding that causation has or has not been established based on new evidence.
Timeline — How we got here
10 updates · append-onlyOfficial confirmationACOG practice advisory: no causal link; acetaminophen remains first-line
ACOG reaffirmed acetaminophen as the analgesic and antipyretic of choice in pregnancy and stated that the current weight of evidence does not support a causal link to neurodevelopmental disorders.
Claims & evidence
Each claim is tracked separately — not a single verdict.Multiple observational studies have reported an association between prenatal acetaminophen exposure and increased autism, ADHD, or related neurodevelopmental outcomes in children.
Evidence basis- May 9, 2013Prenatal and perinatal analgesic exposure and autism: an ecological link
Ecological analysis reported country-level correlations between indicators of prenatal and perinatal paracetamol exposure and autism/ASD prevalence, while noting ecological designs cannot establish causality.
- December 21, 2015Maternal use of acetaminophen during pregnancy and risk of autism spectrum disorders in childhood: A Danish national birth cohort study
In a prospective Danish cohort of 64,322 children, prenatal acetaminophen use was associated with ASD accompanied by hyperkinetic symptoms (HR 1.51), but not with other ASD cases.
- April 24, 2018Prenatal Exposure to Acetaminophen and Risk for Attention Deficit Hyperactivity Disorder and Autistic Spectrum Disorder: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Cohort Studies
Pooled observational estimates associated prenatal acetaminophen with higher risk of ADHD (RR 1.34) and ASD (RR 1.19), with caution that evidence remains observational and susceptible to bias.
- April 1, 2019Use of Negative Control Exposure Analysis to Evaluate Confounding: An Example of Acetaminophen Exposure and Attention-Deficit/Hyperactivity Disorder in Nurses' Health Study II
Only acetaminophen use at the time of pregnancy was associated with childhood ADHD (OR 1.34); associations for pre- and post-pregnancy negative-control periods were null.
- October 30, 2019Association of Cord Plasma Biomarkers of In Utero Acetaminophen Exposure With Risk of Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder in Childhood
Cord plasma biomarkers of fetal acetaminophen exposure were associated with significantly increased risk of childhood ADHD and ASD in a dose-response fashion.
- September 23, 2021Paracetamol use during pregnancy - a call for precautionary action
Consensus statement summarizing experimental and epidemiological research suggesting prenatal acetaminophen exposure might increase risks of some neurodevelopmental disorders, including ADHD and autism spectrum disorder, and calling for precautionary use.
Existing observational evidence does not establish that prenatal acetaminophen exposure causes autism.
Evidence basis- September 23, 2025Acetaminophen Use in Pregnancy and Neurodevelopmental Outcomes
"The current weight of evidence does not support a causal link between prenatal acetaminophen use and neurodevelopmental disorders."
- April 9, 2024Acetaminophen Use During Pregnancy and Children's Risk of Autism, ADHD, and Intellectual Disability
In sibling-control analyses of a Swedish nationwide cohort of about 2.5 million children, acetaminophen use during pregnancy was not associated with autism (HR 0.98), ADHD (HR 0.98), or intellectual disability.
- March 1, 2022Paracetamol use in pregnancy - caution over causal inference from available data
Peer-reviewed commentary cautioning against drawing causal inferences about prenatal paracetamol use and neurodevelopmental outcomes from the available observational evidence.
- March 1, 2022Handle with care - interpretation, synthesis and dissemination of data on paracetamol in pregnancy
Peer-reviewed commentary urging careful interpretation, synthesis, and public communication of evidence on paracetamol use in pregnancy.
- September 22, 2025FDA Responds to Evidence of Possible Association Between Autism and Acetaminophen Use During Pregnancy
"while an association between acetaminophen and neurological conditions has been described in many studies, a causal relationship has not been established and there are contrary studies in the scientific literature."
The federal multidistrict litigation excluded plaintiffs' general-causation expert testimony under Rule 702, substantially affecting the litigation.
Evidence basis- December 18, 2023In re: Acetaminophen - ASD/ADHD Products Liability Litigation, Daubert Order
The court excluded general-causation expert testimony after evaluating admissibility under Rule 702.
What this doesn’t establish
Claims commonly associated with this story that the available evidence does not establish. Confirming a narrow fact here is not confirmation of the broader narrative around it. As such, these claims are not included in the claims bar above.
The existence of lawsuits establishes that Tylenol causes autism.
Evidence basis- December 18, 2023In re: Acetaminophen - ASD/ADHD Products Liability Litigation, Daubert Order
Court proceedings evaluate legal claims and expert evidence; they do not by themselves establish medical causation.
Current evidence establishes that acetaminophen carries no possible neurodevelopmental risk under any circumstance during pregnancy.
Evidence basis- September 23, 2025Acetaminophen Use in Pregnancy and Neurodevelopmental Outcomes
ACOG reaffirms acetaminophen as first-line therapy in pregnancy while noting that research continues and counseling should acknowledge study limitations.
- September 23, 2021Paracetamol use during pregnancy - a call for precautionary action
Scientists and clinicians called for precautionary limits on prenatal paracetamol use while research into potential neurodevelopmental and other developmental risks continues.
Help improve this story
Point us at a source, a mistake, or a framing problem. Every submission is reviewed by a human before anything changes — this is not a vote on what’s true.
Confidence last reviewed July 8, 2026. Updates are append-only; nothing here is edited silently.
Soon you'll be able to follow a story and get notified when the evidence changes.